Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431704
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Alimera Sciences
  • Allergan, Plc.
  • Clearside Biomedical
  • EyeGate Pharma
  • Graybug Vision Inc.
  • Ocular Therapeutix
  • MORE
Ocular Drug Delivery Technology Market - Growth, Future Prospects and Competitive Analysis, 2017-2025, the global ocular drug delivery technology market was valued at US$ 15,500 Mn in 2016, and is expected to reach US$ 25,697 Mn by 2025, expanding at a CAGR of 5.81% from 2017 to 2025.

Market Insights

Ocular drug delivery technology market is growing owing to rising prevalence of eye disorders. The complex of eye anatomy makes the treatment to be very challenging, hence innovations in ophthalmic treatment is still emerging with potential benefits. Presently available therapies not proven to be sufficient to treat every possible sites of eye, therefore enhanced product formulation with improved technology became vital. According to the statistics of World Health Organizations, 285 million people are visually impaired across the world and this global burden of eye disorder is increasing with rapidly growing ageing population. WHO has taken an initiative named VISION 2020 to abolish the possible causes of blindness and provide better eye-care infrastructure to make easily accessible eye-care.

The ocular drug delivery technology market is predicted to experience substantial growth due to growing elderly population, increasing medical interventions and increasing prevalence of eye diseases. The increasing adoption of technologically advanced products, healthcare expenditure for R&D to develop innovative products boost up the growth of the ocular drug delivery technology market.

The ocular drug delivery technology market is classified on the basis of technology type and the classifications are of below types:
  • Topical
  • Ophthalmic injection/Intravitreal injection
  • Ocular insert
  • Ocular implant
  • Others
Topical treatment dominates the overall market of ocular drug delivery technology in terms of technology types.

The ocular drug delivery technology market is further segmented on the basis of indication and the sub-segments are as follows:
  • Cataract
  • Glaucoma
  • Age related macular degeneration
  • Diabetic Retinopathy
  • Eye infection
  • Dry eyes
  • Others
Geographically, in the year 2016, North America held the major share of ocular drug delivery technology market followed by Europe. The increasing burden of visual impairment is majorly due to cataract, glaucoma or diabetes which is directly correlated with ageing population. The increasing R&D expenditure in healthcare research to develop innovative products to obtain improved outcomes and the acceptance of the new technologies among the healthcare professionals boost up the ocular drug delivery technology market growth. The developing eye-care infrastructure, huge number of population suffering from eye disorders and increasing elderly population fuel the growth of the ocular drug delivery technology market in Asia-Pacific region and it is expected to face significant growth in upcoming years due to the growing trend of health awareness among public.

Market Competition Assessment

The ocular drug delivery technology market currently contains multiple companies having their products marketed. The manufacturers are developing new innovative products and the market is growing due to increasing adoption and accessibilities of these products. The companies include Alimera Sciences, Valeant Pharmaceuticals International, Inc., Ocular Therapeutix, Inc., Allergan, Plc., Clearside Biomedical, EyeGate Pharma, Envisia Therapeutics, Inc., Graybug Vision Inc., and others.

Key Market Movements:
  • The rising prevalence of eye disorder, growing ageing population, rising public awareness, increasing number of medical intervention, expanding eye-care set up to reduce global burden of eye diseases, increasing healthcare expenditure for R&D to manufacture newer and innovative products boost up the growth of ocular drug delivery technology market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alimera Sciences
  • Allergan, Plc.
  • Clearside Biomedical
  • EyeGate Pharma
  • Graybug Vision Inc.
  • Ocular Therapeutix
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Ocular Drug Delivery Technology Market Portraiture
2.2 Ocular Drug Delivery Technology Market, by Technology Type, 2016 (US$ Mn)
2.3 Ocular Drug Delivery Technology Market, by Indication Type, 2016 (US$ Mn)
2.4 Ocular Drug Delivery Technology Market, by Geography, 2016 (Value %)

Chapter 3 Global Ocular Drug Delivery Technology Market Analysis
3.1 Global Ocular Drug Delivery Technology Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Ocular Drug Delivery Technology Market, 2016 (Value %)

Chapter 4 Global Ocular Drug Delivery Technology Market Analysis, By Technology Type
4.1 Overview
4.1.1 Market Attractive Proposition of Ocular Drug Delivery Technology Market, by Technology Type, 2016
4.2 Topical Medication
4.4 Ocular Insert
4.5 Ocular Implant
4.6 Others

Chapter 5 Global Ocular Drug Delivery Technology Market Analysis, By Indication Type
5.1 Overview
5.1.1 Market Attractive Proposition of Ocular Drug Delivery Technology Market, by Indication Type, 2016
5.3 Glaucoma
5.4 Age Related Macular Degeneration

Chapter 6 Global Ocular Drug Delivery Technology Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Ocular Drug Delivery Technology Market, by Technology Type, 2015-2025 (US$ Mn)
6.2.2 North America Ocular Drug Delivery Technology Market, by Indication Type, 2015-2025 (US$ Mn)
6.2.3 North America Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Ocular Drug Delivery Technology Market, by Technology Type, 2015-2025 (US$ Mn)
6.3.2 Europe Ocular Drug Delivery Technology Market, by Indication Type, 2015-2025 (US$ Mn)
6.3.3 Europe Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Ocular Drug Delivery Technology Market, by Technology Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Ocular Drug Delivery Technology Market, by Indication Type, 2015-2025 (US$ Mn)
6.4.3 Asia - Pacific Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Ocular Drug Delivery Technology Market, by Technology Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Ocular Drug Delivery Technology Market, by Indication Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Ocular Drug Delivery Technology Market, by Technology Type, 2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Ocular Drug Delivery Technology Market, by Indication Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Alimera Sciences
7.2 Valeant Pharmaceuticals International, Inc.
7.3 Ocular Therapeutix
7.4 Allergan, Plc.
7.5 Clearside Biomedical
7.6 EyeGate Pharma
7.7 Envisia Therapeutics, Inc.
7.8 Graybug Vision Inc.
7.9 Others

List of Figures
Fig. 1 Ocular Drug Delivery Technology Market: Research Methodology
Fig. 2 Ocular Drug Delivery Technology Market, by Technology Type, 2016 (US$ Mn)
Fig. 3 Ocular Drug Delivery Technology Market, by Indication Type, 2016 (US$ Mn)
Fig. 4 Ocular Drug Delivery Technology Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition
Fig. 6 Competitive Analysis: Global Ocular Drug Delivery Technology Market, 2016 (Value %)
Fig. 7 Global Topical Medication Market (US$ Mn), 2015-2025
Fig. 8 Global Ophthalmic Injection/Intravitreal Injection Market (US$ Mn), 2015-2025
Fig. 9 Global Ocular Insert Market (US$ Mn), 2015-2025
Fig. 10 Global Ocular Implant Market (US$ Mn), 2015-2025
Fig. 11 Global Others Market (US$ Mn), 2015-2025
Fig. 12 Global Cataract Market (US$ Mn), 2015-2025
Fig. 13 Global Glaucoma Market (US$ Mn), 2015-2025
Fig. 14 Global Age Related Macular Degeneration Market (US$ Mn), 2015-2025
Fig. 15 Global Diabetic Retinopathy Market (US$ Mn), 2015-2025
Fig. 16 Global Eye Infection Market (US$ Mn), 2015-2025
Fig. 18 Global Dry Eyes Market (US$ Mn), 2015-2025
Fig. 19 Global Others Market (US$ Mn), 2015-2025

List of Tables
Table 1 Global Ocular Drug Delivery Technology Market, By Technology Type (US$ Mn), 2015- 2025 (Value)
Table 2 Global Ocular Drug Delivery Technology Market, By Indication Type (US$ Mn), 2015- 2025 (Value)
Table 3 Global Ocular Drug Delivery Technology Market, by Geography, 2015 - 2025 (US$ Mn)
Table 4 North America Ocular Drug Delivery Technology Market, by Technology Type, 2015 - 2025 (US$ Mn)
Table 5 North America Ocular Drug Delivery Technology Market, by Indication Type, 2015 - 2025 (US$ Mn)
Table 6 North America Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Europe Ocular Drug Delivery Technology Market, by Technology Type, 2015 - 2025 (US$ Mn)
Table 8 Europe Ocular Drug Delivery Technology Market, by Indication Type, 2015 - 2025 (US$ Mn)
Table 9 Europe Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Asia Pacific Ocular Drug Delivery Technology Market, by Technology Type, 2015 - 2025 (US$ Mn)
Table 11 Asia Pacific Ocular Drug Delivery Technology Market, by Indication Type, 2015 - 2025 (US$ Mn)
Table 12 Asia - Pacific Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Latin America Ocular Drug Delivery Technology Market, by Technology Type, 2015 - 2025 (US$ Mn)
Table 14 Latin America Ocular Drug Delivery Technology Market, by Indication Type, 2015 - 2025 (US$ Mn)
Table 15 Latin America Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
Table 16 Middle East and Africa Ocular Drug Delivery Technology Market, by Technology Type, 2015 - 2025 (US$ Mn)
Table 17 Middle East and Africa Ocular Drug Delivery Technology Market, by Indication Type, 2015 - 2025 (US$ Mn)
Table 18 Middle East and Africa Ocular Drug Delivery Technology Market, by Country, 2015 - 2025 (US$ Mn)
Table 19 Alimera Sciences: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 20 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 21 Sonoma Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 22 Allergan, Plc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 23 Clearside Biomedical: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 24 EyeGate Pharma: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News overage)
Table 25 Envisia Therapeutics, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 26 Graybug Vision Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 27 Others: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Alimera Sciences
  • Valeant Pharmaceuticals International, Inc.
  • Ocular Therapeutix
  • Allergan, Plc.
  • Clearside Biomedical
  • EyeGate Pharma
  • Envisia Therapeutics, Inc.
  • Graybug Vision Inc.
  • Others
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll